Description:
A compound being tested in clinical trials to treat neoplasia and leukemias.

Text:
Idasanutlin is being tested in clinical 
trials to treat neoplasia and leukemias 8. Another representative example is Venetoclax a BCL2 
inhibitor approved for clinical use to treat chronic lymphocytic leukemia and certain types of small 
lymphocytic lymphoma 9 (Figure 1). Figure 1. Examples of proteinprotein interaction inhibitors currently approved for clinical use or under 
clinical trials. Different compound databases of PPI inhibitors have been created. For example, TIMBAL 10, the 
Inhibitors of ProteinProtein Interaction Database (iPPIDB) 11, the FrPPIChem, and the databases
